These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 283722)

  • 1. Clinical outcome with naltrexone.
    Resnick RB; Washton AM
    Ann N Y Acad Sci; 1978; 311():241-7. PubMed ID: 283722
    [No Abstract]   [Full Text] [Related]  

  • 2. Abstinence treatments for opiate addicts: therapeutic community or naltrexone?
    Arndt I; McLellan AT; O'Brien CP
    NIDA Res Monogr; 1984 Mar; 49():275-81. PubMed ID: 6434972
    [No Abstract]   [Full Text] [Related]  

  • 3. Naltrexone in the treatment of opiate dependence.
    Resnick RB; Washton AM; Thomas MA; Kestenbaum RS
    NIDA Res Monogr; 1978; (19):321-32. PubMed ID: 218108
    [No Abstract]   [Full Text] [Related]  

  • 4. Naltrexone in a behavioral treatment program.
    O'Brien C; Greenstein R
    NIDA Res Monogr; 1976 Sep; (9):136-40. PubMed ID: 63915
    [No Abstract]   [Full Text] [Related]  

  • 5. Use of narcotic antagonists (naltrexone) in an addiction treatment program.
    Lewis D; Hersch R; Black R; Mayer J
    NIDA Res Monogr; 1976 Sep; (9):99-105. PubMed ID: 794728
    [No Abstract]   [Full Text] [Related]  

  • 6. Patient response to naltrexone: issues of acceptance, treatment effects, and frequency of administration.
    Curran S; Savage C
    NIDA Res Monogr; 1976 Sep; (9):67-9. PubMed ID: 794722
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical experience with naltrexone in a behavioral research study: an interim report.
    Greenstein R; O'Brien C; Mintz J; Woody G; Hanna N
    NIDA Res Monogr; 1976 Sep; (9):141-9. PubMed ID: 794715
    [No Abstract]   [Full Text] [Related]  

  • 8. Varying clinical contexts for administering naltrexone.
    Hurzeler M; Gerwirtz D; Kleber H
    NIDA Res Monogr; 1976 Sep; (9):48-66. PubMed ID: 794721
    [No Abstract]   [Full Text] [Related]  

  • 9. Comments and findings from a naltrexone double blind study.
    Keegan J; Lavenduski C; Schooff K
    NIDA Res Monogr; 1976 Sep; (9):74-6. PubMed ID: 794724
    [No Abstract]   [Full Text] [Related]  

  • 10. Naltrexone treatment of opiate-dependent persons.
    Hollister LE; Schwin RL; Kasper P
    Drug Alcohol Depend; 1977 May; 2(3):203-9. PubMed ID: 880876
    [No Abstract]   [Full Text] [Related]  

  • 11. Naloxone-precipitated withdrawal: a method for rapid induction onto naltrexone.
    Resnick RB; Kestenbaum RS; Washton A; Poole D
    Clin Pharmacol Ther; 1977 Apr; 21(4):409-13. PubMed ID: 849672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An analysis of naltrexone use--its efficacy, safety and potential.
    Landsberg R; Taintor Z; Plumb M; Amico L; Wicks N
    NIDA Res Monogr; 1976 Sep; (9):106-13. PubMed ID: 1004529
    [No Abstract]   [Full Text] [Related]  

  • 13. The development of sustained action preparations of narcotic antagonists.
    Willette RE
    NIDA Res Monogr; 1978; (19):333-9. PubMed ID: 218109
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical experiences with naltrexone in 370 detoxified addicts.
    Thomas M; Kauders F; Harris M; Cooperstein J; Hough G; Resnick R
    NIDA Res Monogr; 1976 Sep; (9):88-92. PubMed ID: 794726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Update of naltrexone treatment.
    O'Brien CP; Greenstein R; Woody GE
    NIDA Res Monogr; 1978; (19):315-20. PubMed ID: 218107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Narcotic antagonist treatment of the criminal justice patient-institutional vs outpatient-including a 24 hour detox naltrexone induction regimen with oral medication.
    Brahen L; Wiechert V; Capone T
    NIDA Res Monogr; 1976 Sep; (9):93-8. PubMed ID: 794727
    [No Abstract]   [Full Text] [Related]  

  • 17. Clonidine hydrochloride detoxification from methadone treatments: the value of naltrexone aftercare.
    Rawson RA; Washton AM; Resnick RB; Tennant FS
    NIDA Res Monogr; 1981 Feb; 34():101-8. PubMed ID: 6783916
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical efficacy of naltrexone: a one year follow up.
    Resnick R; Aronoff M; Lonborg G; Kestenbaum R; Kauders F; Washton A; Hough G
    NIDA Res Monogr; 1976 Sep; (9):114-7. PubMed ID: 1088899
    [No Abstract]   [Full Text] [Related]  

  • 19. Development of injectable microcapsules for use in the treatment of narcotic addiction.
    Thies C
    Natl Inst Drug Abuse Res Monogr Ser; 1975; (4):19-20. PubMed ID: 1241971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short-term effects of naltrexone in 155 heroin ex-addicts.
    Volavka J; Resnick RB; Kestenbaum RS; Freedman AM
    Biol Psychiatry; 1976 Dec; 11(6):679-85. PubMed ID: 999987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.